The impact of diabetes on workforce participation: results from a national household sample.
暂无分享,去创建一个
[1] A. Krolewski,et al. Mortality from cardiovascular diseases among diabetics , 1977, Diabetologia.
[2] Anke Richter,et al. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. , 2002, JAMA.
[3] A. Barsky,et al. Forgetting, fabricating, and telescoping: the instability of the medical history. , 2002, Archives of internal medicine.
[4] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[5] H. Birnbaum,et al. Productivity and medical costs of diabetes in a large employer population. , 2002, Diabetes care.
[6] J. Cauley,et al. Diabetes and incidence of functional disability in older women. , 2002, Diabetes care.
[7] L S Geiss,et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. , 2001, Diabetes care.
[8] Suzanne G. Leveille,et al. Diabetes and physical disability among older U.S. adults. , 2000, Diabetes care.
[9] C. O'muircheartaigh,et al. Telescoping of landmark events: implications for survey research. , 2000, Public opinion quarterly.
[10] R. de Marco,et al. Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. , 1999, Diabetes care.
[11] R. Baumgartner,et al. Prevalences of Type 2 Diabetes, the Insulin Resistance Syndrome, and Coronary Heart Disease in an Elderly, Biethnic Population , 1998, Diabetes Care.
[12] W. Manning,et al. The logged dependent variable, heteroscedasticity, and the retransformation problem. , 1998, Journal of health economics.
[13] K. Flegal,et al. Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.
[14] N. Ray,et al. Economic Consequences of Diabetes Mellitus in the U.S. in 1997 , 1998, Diabetes Care.
[15] R. Hayward,et al. Estimated Benefits of Glycemic Control in Microvascular Complications in Type 2 Diabetes , 1997, Annals of Internal Medicine.
[16] D. Hadden,et al. Macrovascular disease and hyperglycaemia: 10‐year survival analysis in Type 2 diabetes mellitus: the Belfast diet study , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[17] K. Alberti. The Clinical Implications of Impaired Glucose Tolerance , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[18] C. Weel,et al. Cardiovascular Morbidity and Mortality in Type 2 Diabetic Patients: a 22‐year Historical Cohort Study in Dutch General Practice , 1995, Diabetic medicine : a journal of the British Diabetic Association.
[19] R. Suzman,et al. An Overview of the Health and Retirement Study , 1995 .
[20] J. Tuomilehto,et al. Diabetes and the risk of stroke. , 1993, Journal of diabetes and its complications.
[21] E. Barrett-Connor,et al. Prevalence of Cardiovascular and Renal Complications in Older Adults With Normal or Impaired Glucose Tolerance or NIDDM: A population-based study , 1993, Diabetes Care.
[22] T. Orchard,et al. Diabetes Mellitus and Macrovascular Complications: An epidemiological perspective , 1992, Diabetes Care.
[23] R. Klein,et al. Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.
[24] M. Harris. Epidemiology of diabetes mellitus among the elderly in the United States. , 1990, Clinics in geriatric medicine.
[25] G A Colditz,et al. The economic costs of non-insulin-dependent diabetes mellitus. , 1989, JAMA.
[26] D. Reed,et al. Diabetes and the risk of stroke. The Honolulu Heart Program. , 1987, JAMA.
[27] C. Morris,et al. A Comparison of Alternative Models for the Demand for Medical Care , 1983 .
[28] P. McNamara,et al. Morbidity and Mortality in Diabetics In the Framingham Population: Sixteen Year Follow-up Study , 1974, Diabetes.